Intravenous immunoglobulin (IVIg) is issued in accordance with the Criteria for the Clinical Use of Intravenous Immunoglobulin in Australia.
The criteria were developed and funded under the National Blood Agreements to assist clinicians and transfusion medicine professionals to identify conditions and circumstances for the appropriate use of IVIg:
Comparison of Intragam® P, Flebogamma 5% DIF and Octagam® 26 KB
IVIg can be obtained under National Blood Supply or Direct Order arrangements. Refer to the National Blood Authority website about the supply of IVIg in Australia.
Supply Arrangements for Intravenous Immunoglobulin (IVIg) in Australia 47 KB
Prescription of these products often requires specialist consultation. Always read and refer to the product information sheet of every product prior to administration.
► Download IVIg request forms according to your State or Territory
|
|
|
Intragam® P (3 g in 50 mL & 12 g in 200 mL vials) |
Intragam® P is a plasma-derived intravenous immunoglobulin solution.
IVIg is used for patients who need replacement of antibodies and also for autoimmune disorders.
Refer to the Criteria for the Clinical Use of IVIg for specific indications and product information sheet for further information.
This product is domestically produced and accessed under the National Blood Supply (NBS) arrangement.
| Title: | |
| Authors: | Dr Elizabeth Campbell and Dr Joanne Pink |
| Description: | Information from CSL Biotherapies and the Australian Red Cross Blood Service about the redesign of Albumex® and Intragam P® Stoppers. |
| Date modified: | 11 November 2011 |
Intragam® P product information [on www.csl.com.au]
This link takes you to CSL's web information about Intragam® P. You can download the product information (PI) sheet from this web page.
The PI details the pharmacology, indications, contraindications, precautions, adverse effects, use in pregnancy & lactation, adverse effects, and dosage & administration of Intragam® P.
|
|
|
Octagam® 50 mg/mL solution |
Octagam® is a plasma-derived intravenous immunoglobulin solution. IVIg is used for patients who need replacement of antibodies and also for autoimmune disorders.
Refer to the Criteria for the Clinical Use of IVIg for specific indications and product information sheet for further information.
This is an imported product that is used to meet any shortfalls in the availability of domestically-produced Intragam® P.
Information on ordering and pricing is outlined in the National Blood Authority website.
Octagam® product information [on www.octapharma.com]
This link takes you to Octapharma's web information about Octagam®. You can download the product information (PI) sheet from this web page.
The PI details the pharmacology, indications, contraindications, precautions, adverse effects, use in pregnancy & lactation, adverse effects, and dosage & administration of Octagam®.
|
|
| Kiovig |
Kiovig 10% is a plasma-derived intravenous immunoglobulin solution. IVIg is used for patients who need replacement of antibodies and also for autoimmune disorders.
| Title: | Kiovig 10% Product Information |
| Publisher: | Baxter |
| Description: | This product information details the pharmacology, indications, contraindications, precautions, adverse effects, use in pregnancy & lactation, adverse effects, and dosage & administration of Kiovig 10%. |
| Date modified: | 2011 |
Refer to the Criteria for the Clinical Use of IVIg for specific indications and product information sheet for further information.
This is an imported product. Information on ordering and pricing is outlined in the National Blood Authority website.
|
|
|
Flebogamma |
Flebogamma 5% DIF is a plasma-derived intravenous immunoglobulin solution.
IVIg is used for patients who need replacement of antibodies and also for autoimmune disorders.
Refer to the Criteria for the Clinical Use of IVIg for specific indications and to its product information sheet for further information.
This is an imported product. Information on ordering and pricing is outlined in the National Blood Authority website.
| Title: | Flebogamma 5% DIF product information |
| Publisher: | Lateral Grifols |
| Description: | This product information details the pharmacology, indications, contraindications, precautions, adverse effects, use in pregnancy & lactation, adverse effects, and dosage & administration of Flebogamma 5% DIF. |
| Date modified: | October 2008 |